31
William W Ruehl, David S Bruyette, David Stevens: Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushings disease). Deprenyl Animal Health, Zarley McKee Thomte Voorhees & Sease, March 9, 1993: US05192808 (18 worldwide citation)

A method of treating Cushing's Disease comprising treating mammals, and especially humans, dogs, horses or ponies with from 0.01 to about 4.0 mg/kg of body weight of L-Deprenyl, preferably daily, to achieve and maintain remission.


32
Roosenschoon Pieter Lieuwe, Loosveld Serge Louis: Method and device for automatically observing the behavior of animals.. Nedap, November 17, 1994: EP0624313-A1 (17 worldwide citation)

Method and apparatus for automatically observing the behavior of animals using at least one automatic identification unit. The identification unit can be mounted at several places in a space where domestic animals are housed, for instance the entrance of the milk parlor (14), a feeding station (10,1 ...


33

34
David E Junker, Mark D Cochran: Neutralizing GDF8 epitope-based growth enhancing vaccine. Schering Plough Animal Health Corporation, May 13, 2008: US07371726 (16 worldwide citation)

The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods ...


35
Bruno Tocque, Laurent Bracco, Fabien Schweighoffer: Methods and composition for the detection of pathologic events. Exonhit Therapeutics, Kristina Bieker Brady Ph D, Clark & Elbing, April 16, 2002: US06372432 (16 worldwide citation)

The present invention concerns new compositions and methods for the detection of pathological events. It more specifically concerns methods for the detection in vitro of the presence of a pathology or a pathological event in a subject, comprising taking a sample of blood cells from the subject and d ...


36
Crooks Michael John: Non-aqueous micellar solutions of various drugs.. Crooks Michael John, May 15, 1991: EP0427582-A2 (15 worldwide citation)

A non-aqueous micellar solution, for use in animal health, of one or more non water-soluble Anthelmintics and or Insect Growth Regulators in a polyethoxylated oil or fat surfactant and one or more co-solvents chosen from a group comprising Dimethyl Sulphoxide (DMSO), N-Methyl Pyrollidone (NMP), Tetr ...


37
Norton W Milgram: Use of 1-deprenyl for retention of specific physiological functions. Deprenyl Animal Health, Zarley McKee Thomte Voorhees & Sease, July 6, 1993: US05225446 (14 worldwide citation)

1-Deprenyl and pharmaceutically acceptable analog forms thereof are used at specific dosage levels and frequency of dosage to slow the normal age dependent deterioration of renal function, to provide increased exploratory behavior level of activity at any given age and in order to retard age deterio ...


38
Norton W Milgram: Use of L-deprenyl for retention of specific physiological functions. Deprenyl Animal Health, Zarley McKee Thomte Voorhees & Sease, September 29, 1992: US05151449 (14 worldwide citation)

L-Deprenyl and pharmaceutically acceptable analog forms thereof are used at specific dosage levels and frequency of dosage to slow the normal age dependent deterioration of renal function, to provide increased exploratory behavior level of activity at any given age and in order to retard age deterio ...


39

40
Hatsuo Shibatani, Tomoyasu Nakamura: Stabilized preparations of &bgr;-lactam antibiotic. Takeda Schering Plough Animal Health, Oblon Spivak McClelland Maier & Neustadt P C, February 4, 2003: US06514962 (13 worldwide citation)

Stabilized preparations which contain a &bgr;-lactam antibiotic having an esterified carboxyl group attached directly to the mother nucleus, an oil and a phosphate.